Michael T. Lotze

81.9k citations
504 papers · 57.5k indexed · 27 hit papers · h-index 116
Topics
Immunotherapy and Immune Responses (153 papers)Immune Cell Function and Interaction (100 papers)Cancer Immunotherapy and Biomarkers (74 papers)

In The Last Decade

Michael T. Lotze

498 papers receiving 56.1k citations

Hit Papers

A Progress Report on the Treatment of 157 Patients with A...19812026199620111987200519852011198850010001.5k2.0k

Peers

Michael T. Lotze
Comparison fields: 5 of 187
  • Immunology 26.0k
  • Molecular Biology 20.4k
  • Oncology 17.2k
  • Epidemiology 8.4k
  • Pulmonary and Respiratory Medicine 7.7k
Replace Lorenzo Galluzzi with:
Lorenzo Galluzzi France
Simon C. Watkins United States
Russell Ross United States
Jürg Tschopp Switzerland
Peter Vandenabeele Belgium
Herbert J. Zeh United States
Josef Penninger Austria
Daolin Tang United States
Luke O'neill Ireland
Vishva M. Dixit United States
Michael T. Lotze relative to Lorenzo Galluzzi France Lorenzo Galluzzi's profile →
Citations per field
00.5×1.5×
Lorenzo Galluzzi · 1×
Citations per year

Countries citing papers authored by Michael T. Lotze

Since Specialization
Citations

This map shows the geographic impact of Michael T. Lotze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Lotze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Lotze more than expected).

Fields of papers citing papers by Michael T. Lotze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Lotze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Lotze. The network helps show where Michael T. Lotze may publish in the future.

Co-authorship network of co-authors of Michael T. Lotze

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Lotze. A scholar is included among the top collaborators of Michael T. Lotze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Lotze. Michael T. Lotze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 13
3 23
4 3
5 8
6 170
7 38
8 57
9 110
10 135
11
HSPA5 Regulates Ferroptotic Cell Death in Cancer Cellsbreakdown →
447
12 66
13 78
14 125
15 220
16 115
17 26
18
Dicer-regulated micro RNAs 222 and 339 promote immune-escape of cancer cells through downregulation of ICAM-1
1
19
Treatment of 9L gliosarcoma with IL-4 producing 9L vaccine
3
20 2

About Michael T. Lotze

Michael T. Lotze is a scholar working on Immunology, Clinical Biochemistry and Oncology, having authored 504 papers that have together received 57.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (153 papers), Immune Cell Function and Interaction (100 papers) and Cancer Immunotherapy and Biomarkers (74 papers). The work is most often cited by research in Immunology (26.0k citations), Clinical Biochemistry (6.3k citations) and Oncology (17.2k citations). Michael T. Lotze has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Daolin Tang, Herbert J. Zeh, Rui Kang, Steven A. Rosenberg, Kevin J. Tracey, Herbert J. Zeh, Claudia A. Seipp, Timothy R. Billiar, Walter J. Storkus and R Kang. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026